|
TOP STORY
Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation. » More
|
Continuing Education
Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
| TODAY'S HEADLINES
When patients with coronary stents require surgery while on dual-antiplatelet therapy, eptifibatide (Integrilin) bridging appears safe, researchers from Cleveland Clinic report. » More
|
|
Men with advanced prostate cancer treated with investigational enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life compared with placebo, according to new data from the phase 3 AFFIRM study. » More
|
|
Investigational afatinib used in non-small cell lung cancer treatment helped patients live longer compared with pemetrexed/cisplatin. » More |
|
|
Like
Tweet
